Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

and Roche Holding (RHHBY – Research Report). Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

A linkurl:paper;http://www.pnas.org/cgi/doi/10.1073/pnas.0604351103 published this week in PNAS provides a possible glimpse at the near-term future of linkurl:next ...

The Japanese government has allocated a JPY 454 million grant for the community development activities in the Bangsamoro Autonomous Region in Muslim Mindanao (BARMM). According to the Japan Embassy in ...

Additionally, catch up on recent company news and funding outcomes. This presentation provided an insight into Roche’s (Basel, Switzerland) novel next-generation sequencing technology, sequencing by ...

Further, the US with USD 41.8 billion market in 2023, holds majority share in the global In-vitro Diagnostics market and is likely to remain the leading region growing a CAGR of 5.0% within this ...

with investors also concerned about Illumina’s product sales taking a hit due to U.S. research funding cuts and looming competition from Roche’s gene-sequencing device. Morningstar analyst Jul ...